Communiqués PreveCeutical Medical Inc.

Actions

CA74141E1043

Temps Différé Canadian Securities Exchange Autres places de cotation 20:13:41 12/07/2024			Varia. 5j.	Varia. 1 janv.
0,02 ^CAD	0,00 %		0,00 %	-20,00 %

05/07	PreveCeutical Medical Inc. annonce ses résultats pour le premier trimestre terminé le 31 mars 2024	CI
28/06	PreveCeutical Medical Inc. annonce ses résultats pour l'année complète terminée le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Preveceutical Announces Revocation of Management Cease Trade Order	09/07	NE
PreveCeutical Provides Update on Management Cease Trade Order	29/06	NE
PreveCeutical Enters into Loan Agreements	17/06	NE
PreveCeutical Provides Update on Management Cease Trade Order	14/06	NE
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence	06/06	NE
Preveceutical Provides Update on Management Cease Trade Order	30/05	NE
Preveceutical Announces First Tranche Closing of Private Placement	30/05	NE
PreveCeutical Medical : Announces First Tranche Closing of Private Placement	30/05	PU
PreveCeutical Provides Update on Management Cease Trade Order	17/05	NE
PreveCeutical Announces Management Cease Trade Order	03/05	NE
PreveCeutical Medical : Showcases Dynamic Evolution in AI Strategy	12/09/23	PU
PreveCeutical Engages New to the Street for Production and Broadcasting Services	01/09/23	AQ
PreveCeutical Medical : Engages New to the Street for Production & Broadcasting Services	31/08/23	PU
PreveCeutical Medical : Files Cyclic Peptides And Uses Thereof in the EU and Australia	24/07/23	PU
PreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use and Cyclic Peptides and Uses Thereof	29/06/23	AQ
PreveCeutical Medical : Files Two Family Patents of Sol-Gel Cannabinoid Formulation And Antiviral Use & Cyclic Peptides And Uses Thereof	28/06/23	PU
PreveCeutical Medical : Sol-Gel and Uses thereof Patent Update	30/05/23	PU
PreveCeutical Medical : Launches Clinical Artificial Intelligence Division	24/04/23	PU
PreveCeutical Medical : Announces Live Interactive Q&A Video Conference	20/04/23	PU
PreveCeutical Medical : Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain	04/04/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués PreveCeutical Medical Inc.

Actions

PREV

CA74141E1043

Communiqués

Filtres